Atea Pharmaceuticals, Inc. logo AVIR - Atea Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 1
HOLD 2
SELL 1
STRONG
SELL 0
| PRICE TARGET: $10.00 DETAILS
HIGH: $10.00
LOW: $10.00
MEDIAN: $10.00
CONSENSUS: $10.00
UPSIDE: 126.24%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 7.82
Quick Ratio 7.82
Solvency Ratio -3.970
Cash Ratio 2.41

Valuation Ratios

Ratio Value
Price/Earnings
-1.84
Hist. avg: 6.1
Peers avg: 14.6
PEG Ratio 0.61
Forward PEG 0.61
Price/Book 1.06
Price/Sales 0.00
Price/FCF -2.20
Price/Op Cash Flow -2.20

Debt Ratios

Ratio Value
Debt/Assets 0.0027
Debt/Equity 0.0031
Debt/Capital 0.0031
Long-Term Debt/Capital 0.0000
Financial Leverage 1.14

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -3.319
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage -206.77
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -156.62
Operating Cash Flow Coverage -156.62
Capital Expenditure Coverage 0.00
Dividend + Capital Expenditure Coverage 0.00

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -1.943
Debt/Share 0.0103
Cash/Share 3.70
Book Value/Share 3.38
Tangible BV/Share 3.38
Equity/Share 3.38
Operating Cash Flow/Share -1.620
Capital Expenditure/Share 0.000
FCF/Share -1.620

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.963
Earnings Before Tax/EBIT 0.909
Price/Fair Value 1.06
Debt/Market Cap 0.0029
Effective Tax Rate 3.7%
Enterprise Value Multiple -1.09